Research Expert: Sarah Overall
  • Published: Jun 2025
  • Pages: 150
  • SKU: IRTNTR75738

  • Latest News- Tourettes Syndrome Drugs Market: Antipsychotics is expected to lead the Product segment during 2025-2029

    The Tourettes Syndrome Drugs Market is being driven by Growing awareness about Tourette syndrome

    The Tourettes Syndrome Drugs Market is expected to grow at a CAGR of 7.1% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 717.1 million. Pharmaceutical companies, including AstraZeneca Plc, Eli Lilly and Co., Johnson & Johnson, and Otsuka Holdings Co. Ltd., are significantly investing in research and development to introduce innovative treatments for Tourette Syndrome. For instance, Scisparc Ltd., an Israeli biopharma, has recently completed the production of its potential drug candidate, SCI-110, which contains dronabinol, a synthetic form of tetrahydrocannabinol (THC). FDA-approved for treating HIV/AIDS-related anorexia and chemotherapy side effects since the late 1990s, dronabinol is now undergoing clinical trials for Tourette Syndrome treatment. This wave of innovation is propelling the expansion of the global Tourettes syndrome drugs market. 

    Get more information on Tourettes Syndrome Drugs Market by requesting a sample report

    Which Factors Are Causing a Surge in Market Growth?

    The market is segmented based on

    • Product
      • Antipsychotics
      • Non-antipsychotics
    • Distribution Channel
      • Offline
      • Online
    • Application
      • Children
      • Adults
    • Geography
      • North America
        • Canada
        • US
      • Europe
        • Germany
        • UK
        • France
        • Italy
        • Spain
      • Asia
        • China
        • India
        • Japan
      • Rest of World (ROW)

      According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

      • Growing awareness about Tourette syndrome
      • Increasing cases of Tourette syndrome across world
      • Increasing demand for cost-effective treatments

      However, the market also witnesses some limitations, which are as follows:

      • Social stigma associated with Tourettes syndrome
      • Side effects associated with Tourettes syndrome drugs
      • Stringent government regulations on Tourettes syndrome drugs

      Benefits of Buying Global Tourettes Syndrome Drugs Market Research Report by Technavio

      Rich Experience: 20+ years leading global market research, trusted insights across industries.

      Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

      Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

      Market Scope in Tourettes Syndrome Drugs Market Research Report

      Market Scope

      Report Coverage

      Details

      Page number

      197

      Base year

      2024

      Historic period

      2019-2023

      Forecast period

      2025-2029

      Growth momentum & CAGR

      Accelerate at a CAGR of 7.1%

      Market growth 2025-2029

      USD 717.1 million

      Market structure

      fragmentation

      YoY growth 2024-2025(%)

      6.5

      Key countries

      US, Germany, China, Canada, UK, France, Italy, Japan, India, and Spain

      Competitive landscape

      Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

      Find out which segment is leading the market by accessing the free PDF report

      Research Analysis Overview

      Tourette's syndrome is a neurodevelopmental disorder characterized by tics, which can be motor or vocal, often beginning in childhood, adolescence, or adulthood. Diagnosis involves clinical evaluation by healthcare professionals, including neurologists and psychiatrists. Treatment options include behavioral therapies, personalized medicine, and genetic research using animal models and clinical trials. Biomarkers, diagnostic tools, and early intervention are crucial for improving quality of life. Prevalence is higher in pediatric cases, and advocacy groups and foundations play a significant role in raising awareness and funding for research. Co-occurring conditions such as ADHD and OCD are common.

      Market Research Overview

      The Tourette's syndrome market is a significant segment of the global pharmaceuticals industry, encompassing entities involved in the research and development (R&D) or production of both generic and non-generic drugs, as well as veterinary drugs. According to Technavio, the healthcare market size is determined by the collective revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The expansion of the global pharmaceuticals market will be fueled by several factors, including the increasing aging population. By 2050, approximately one-quarter of the US population and by 2030 in Europe, are projected to be over the age of 60 years. This demographic shift will lead to a higher demand for pharmaceutical solutions to manage age-related health conditions, including Tourette's syndrome.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.


      Contacts

      Technavio Research
      Jesse Maida
      Media & Marketing Executive
      US: +1 844 364 1100
      UK: +44 203 893 3200
      Email: media@technavio.com
      Website: www.technavio.com/

      Read News Read Less
      Interested in this report?
      Get your sample now!

    Safe and Secure SSL Encrypted

    Technavio

    • 2500 USD

    [5 reports/month/user]

    • 5000 USD

    close
    • Basic Plan [5000 USD/Year]:

      Single User
      Download 5 Reports/Month
      View 100 Reports/Month
      Add upto 3 Users at 625 USD/user

    • Teams Plan [7500 USD/Year]:

      5 User
      Download 5 Reports/Month/User
      View 100 Reports/Month/User
      Add upto 30 Users at 500 USD/user

    *You can upgrade to Teams plan at Subscription page

    close
    • Single:

      One user only.
      Quick & easy download option

    • Enterprise:

      Unlimited user access (Within your organization).
      Complimentary Customization Included

    *For Enterprise license, go to checkout page

    Technavio Get the report (PDF) sent to your email within minutes.